Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

448 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Gene Transfer Study for Hemophilia A

NCT03003533

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of California Davis - Hemostasis and Thrombosis Center Sacramento, California, United States
  • University of Florida Health Gainesville, Florida, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
View all 16 locations
View Trial Details
Completed

Evaluation of ClearLLab LS Screening Panel

NCT05819762

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations
  • Tongji Hospital Wuhan, Hubei, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, China
View Trial Details
Completed

Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

NCT02976753

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Swedish Orphan Biovitrum Research site Innsbruck, Austria
  • Swedish Orphan Biovitrum Research site Linz, Austria
  • Swedish Orphan Biovitrum Research Site Sankt Pölten, Austria
  • Swedish Orphan Biovitrum Research site Vienna, Austria
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

NCT03055611

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Swedish Orphan Biovitrum Reserach site Berlin, Germany
  • Swedish Orphan Biovitrum Reserach Site Blaubeuren Abbey, Germany
  • Swedish Orphan Biovitrum Research Site Bonn, Germany
  • Swedish Orphan Biovitrum Research Site Delmenhorst, Germany
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Research Site (CHU de Bordeaux) Bordeaux, France
  • Swedish Orphan Biovitrum Research Site Brest, France
  • Swedish Orphan Biovitrum Research Site Caen, France
  • Swedish Orphan Biovitrum Research Site Chambéry, France
View all 18 locations
View Trial Details
Completed

Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

NCT01183949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Centre New York, United States
View Trial Details

Related conditions